Marimastat: the clinical development of a matrix metalloproteinase inhibitor

By Thomas A.L.   Steward W.P.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 12, 2000-12 ,pp. : 2913-2922

Informa Healthcare

Access to resources Recommend Favorite

Circulating Serum Matrix Metalloproteinase-3 and Metalloproteinase-9 Are Not Associated with Echocardiographic Parameters of Diastolic Function in Asymptomatic Type 2 Diabetic Patients

By Žákovičová E   Charvat J   Kukacka J   Chlumsky J   Svab P   Kvapil M  

The Journal of International Medical Research, Vol. 38, Iss. 6, 2010-11 ,pp. : 2093-2099

Field House Publishing

Access to resources Recommend Favorite

Levels of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 mRNAs in Patients with Primary Hypertension or Hypertension-induced Atherosclerosis

By Su W   Gao F   Lu J   Wu W   Zhou G   Lu S  

The Journal of International Medical Research, Vol. 40, Iss. 3, 2012-05 ,pp. : 986-994

Field House Publishing

Access to resources Recommend Favorite

Bone Marrow Mononuclear Cell Transplantation Increases Metalloproteinase-9 and 13 and Decreases Tissue Inhibitors of Metalloproteinase-1 and 2 Expression in the Liver of Cholestatic Rats

By  

Cells Tissues Organs, Vol. 198, Iss. 2, 2013-07 ,pp. : 139-148

Karger

Access to resources Recommend Favorite

Corticotropin-releasing Hormone Enhances the Invasiveness and Migration of Ishikawa Cells, Possibly by Increasing Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9

By Jo YH   Choi YJ   Kim HO   Yoon KS   Lee BY   Jung MH   Huh CY  

The Journal of International Medical Research, Vol. 39, Iss. 6, 2011-11 ,pp. : 2067-2075

Field House Publishing

Access to resources Recommend Favorite